Library screening and receptor-directed targeting of gammaretroviral vectors

Future Microbiology

Volumn 8, Issue 1, 2013, Pages 107-121

  Mazari, Peter M ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

DNA shuffling; FeLV; library screening; MLV; murine leukemia virus; pseudotyping; retroviral entry; sindbis Env; viral envelopes; viral receptors; viral retargeting

Indexed keywords

CHIMERIC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; AVIAN LEUKOSIS ONCOVIRUS; DNA SHUFFLING; FELINE LEUKEMIA VIRUS; GIBBON LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS; LENTIVIRINAE; MOLECULAR LIBRARY; MURINE LEUKEMIA VIRUS; NONHUMAN; PERSONALIZED MEDICINE; PORCINE ENDOGENOUS RETROVIRUS; PRIORITY JOURNAL; PSEUDOTYPING; RETICULOENDOTHELIOSIS VIRUS; RETROVIRUS; REVIEW; VIRAL GENE THERAPY; VIRAL TROPISM; VIRUS ISOLATION; VIRUS PARTICLE;

ANIMALS; GAMMARETROVIRUS; GENE LIBRARY; GENETIC VECTORS; HUMANS; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

MURINE LEUKEMIA VIRUS;

EID: 84871412476     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.122     Document Type: Review

References (135)

1. Rosenfeld M, Yoshimura K, Trapnell B et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155 (1992
2. Wagner J, Reynolds T, Morgan M et al. Efficient and persistent gene transfer of A AV-CFTR in maxillary sinus. Lancet 6(351), 1702-1703 (1998
3. Cole D, Wilson M, Baron P et al. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum. Gene. Ther. 11(7), 1381-1394 (1996
4. Blaese R, Culver K, Miller A et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 5235(270), 475-480 (1995
5. Gelinas C, Temin H. Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses. Proc. Natl Acad. Sci. USA 23(83), 9211-9215 (1986
6. Aiuti A, Slavin S, Aker M et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296(5577), 2410-2413 (2002
7. Cavazzana-Calvo M, Hacein-Bey S, Basile GDS et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466), 669-672 (2000
8. Hacein-Bey-Abina S, Le Deist F, Carlier F et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346(16), 1185-1193 (2002
9. Doms RW, Lamb R A, Rose JK, Helenius A. Folding and assembly of viral membrane proteins. Virology 193, 545-562 (1993
10. Battini J-L, Heard JM, Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66(3), 1468-1475 (1992
11. Morgan RA, Nussbaum O, Muenchau DD, Shu L, Couture L, Anderson WF. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J. Virol. 67(8), 4712-4721 (1993
12. Ott D, Rein A. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J. Virol. 66(8), 4632-4638 (1992
13. Han J-Y, Cannon PM, Lai K-M, Zhao Y, Eiden MV, Anderson WF. Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J. Virol. 71(11), 8103-8108 (1997
14. Bupp K, Roth M. Altering retroviral tropism using a random display envelope library. Mol. Ther. 5, 329-335 (2002
15. Rigby MA, Rojko JL, Stewart MA et al. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J. Gen. Virol. 73, 2839-2847 (1992
16. Wallin M, Ekstrom M, Garoff H. The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization. J. Virol. 79(3), 1678-1685 (2005
17. Wallin M, Ekstrom M, Garoff H. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 23(1), 54-65 (2004
18. Freed EO, Martin MA. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70(1), 341-351 (1996
19. Jones JS, Risser R. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67(1), 67-74 (1993
20. Wallin M, Ekström M, Garoff H. Receptor-Triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation. J. Virol. 80(19), 9921-9925 (2006
21. Brojatsch J, Naughton J, Rolls MM, Aingler K, Young JAT. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87, 845-855 (1996
22. Bates P, Rong L, Varmus HE, Young JAT, Crittenden LB. Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus. J. Virol. 72(3), 2505-2508 (1998
23. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of a seven-Transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996
24. Deng H, Liu R, Ellmeier W et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381(6584), 661-666 (1996
25. Manel N, Kim F, Kinet S, Taylor N, Sitbon M, Battini J. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115(4), 449-459 (2003
26. Sarangi A, Bupp K, Roth MJ. Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc. Natl Acad. Sci. USA 104(26), 11032-11037 (2007
27. Mazari PM, Linder-Basso D, Sarangi A, Chang Y, Roth MJ. Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor. Proc. Natl Acad. Sci. USA 106(14), 5848-5853 (2009
28. Siess DC, Kozak SL, Kabat D. Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J. Virol. 70(6), 3432-3439 (1996
29. Cosset F-L, Morling FJ, Takeuchi Y, Weiss RA, Collins MKL, Russell SJ. Retroviral retargeting by envelopes expressing an N-Terminal binding domain. J. Virol. 69, 6314-6322 (1995
30. Martin F, Chowdhury S, Neil SJ, Chester KA, Cosset F-L, Collins MK. Targeted retroviral infection of tumor cells by receptor cooperation. J. Virol. 77(4), 2753-2756 (2003
31. Zhao Y, Zhu L, Lee S et al. Identification of the block in targeted retroviral-mediated gene transfer. Proc. Natl Acad. Sci. USA 96(7), 4005-4010 (1999
32. Somia N, Zoppé M, Verma I. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl Acad. Sci. USA 92(16), 7570-7574 (1995
33. Vogt P. Phenotypc mixing in the avian tumor virus group. Virology 4(32), 708-717 (1967
34. Wilson C, Reitz M, Okayama H, Eiden M. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J. Virol. 63, 2374-2378 (1989
35. Mammano F, Salvatori F, Indraccolo S, Rossi AD, Cheico-Bianchi L, Gottlinger H. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 71(4), 3341-3345 (1997
36. Burns J, Friedmann T, Driever W, Burrascano M, Yee J. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentrated to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl Acad. Sci. USA 17(90), 8033-8037 (1993
37. Strang BL, Takeuchi Y, Relander T et al. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J. Virol. 79(3), 1765-1771 (2005
38. Mentis G, Graveli M, Hamilton R, Shneider N, O'Donovan M, Schubert M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1 based vectors pseudotyped with select rabies virus glycoproteins. J. Neurosci. Methods 157(2), 208-217 (2006
39. Funke S, Maisner A, Muhlenback MD et al. Targeted cell entry of lentiviral vectors. Mol. Ther. 8(16), 1427-1436 (2008
40. Yonezawa A, Cavrois M, Greene WC. Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J. Virol. 79(2), 918-926 (2005
41. Freed EO, Martin MA. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989 (1995
42. Pinter A, Honnen WJ. Topography of murine leukemia virus envelope proteins: Characterization of transmembrane components. J. Virol. 46, 1056-1060 (1983
43. Spector D, Wright EWD, Koval V, Clark C, Jaquish D, Spector S. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64(5), 2298-2308 (1990
44. Stitz J, Buchholz CJ, Engelstädter M et al. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273, 16-20 (2000
45. Christodoulopoulos I, Cannon P. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 75, 4129-4138 (2001
46. Sakuma T, Ravin S, Tonne J et al. Characterization of retroviral and lentiviral vectors pseudotyped with XMRV envelope glycoprotein. Hum. Gene. Ther. 21, 1665-1673 (2010
47. Sandrin V, Boson B, Salmon P et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100, 823-832 (2002
48. Chinen J, Davis J, Ravin SD et al. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. Blood 110, 67-73 (2007
49. Rasko JEJ, Battini J-L, Gottschalk RJ, Mazo I, Miller AD. The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc. Natl Acad. Sci. USA 96, 2129-2134 (1999
50. Green B, Lee S, Rasko J. Biodistribution of the RD114/mammalian type D retrovirus receptor RDR. J. Gene Med. 6, 249-259 (2004
51. Russell S, Hawkins R, Winter G. Retroviral vectors displaying funcional antibody fragments. Nucleic Acids Res. 5(21), 1081-1085 (1993
52. Martin F, Neil S, Kupsch J, Maurice M, Cosset F-J, Collins M. Retrovirus targeting by tropism restriction to melanoma cells. J. Virol. 73(8), 6923-6929 (1999
53. Chu TH, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-Type-specific gene transfer. J. Virol. 69(4), 2659-2663 (1995
54. Urban JH, Schneider RM, Compte M et al. Selection of functional human antibodies from retroviral display libraries. Nucleic Acids Res. 33(4), e35 (2005
55. Schnierle BS, Moritz D, Jeschke M, Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3(4), 334-342 (1996
56. Benedict CA, Tun RYM, Rubinstein DB, Guillaume T, Cannon PM, Anderson WF. Targeting retroviral vectors to CD34- expressing cells: Binding to CD34 does not catalyze virus-cell fusion. Hum. Gene. Ther. 10, 545-557 (1999
57. Tai C, Logg C, Park J, Anderson W, Press M, Kashara N. Antibody-mediated targeting of replication-competent retroviral vectors. Hum. Gene. Ther. 14(8), 789-802 (2003
58. Anliker B, Abel T, Kneissl S et al. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat. Methods 7(11), 929-935 (2010
59. Morizono K, Bristol G, Xie Y, Kung S, Chen I. Antibody-directed targeting of retroviral vectors via cell surface antigens. J. Virol. 75(17), 8016-8020 (2001
60. Morizono K, Xie Y, Ringpis G-E et al. Lentiviral vector retargeting to P-glycoprotein on metastic melanoma through intravenous injection. Nature Med. 11(3), 346-352 (2005
61. Liang M, Pariente N, Morizono K, Chen I. Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells. J. Gene Med. 11(3), 185-196 (2009
62. Morizono K, Xie Y, Olafsen T et al. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 4(9), 286-196 (2011
63. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376 (1994
64. Kayman SC, Park H, Saxon M, Pinter A. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J. Virol. 73, 1802-1808 (1999
65. Rothenberg SM, Olsen MN, Laurent LC, Crowley RA, Brown PO. Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J. Virol. 75(23), 11851-11862 (2001
66. Wu BW, Lu J, Gallaher TK, Anderson WF, Cannon PM. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide. Virology 269, 7-17 (2000
67. Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, Berger JM. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 A resolution. Science 277, 1662-1666 (1997
68. Chadwick M, Morling F, Cosset F, Russell S. Modification of retroviral tropism by display of IGF-I. J. Mol. Biol. 285(2), 485-494 (1999
69. Wu BW, Cannon PM, Gordon EM, Hall FL, Anderson WF. Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72(7), 5383-5391 (1998
70. Gollan TJ, Green MR. Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope. J. Virol. 76(7), 3558-3563 (2002
71. Gollan TJ, Green MR. Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. J. Virol. 76(7), 3564-3569 (2002
72. Yajima T, Kanda T, Yoshiike K, Kitamura Y. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction. Hum. Gene Ther. 9(6), 779-787 (1998
73. Han X, Kasahara N, Kan Y. Ligand-directed retroviral targeting of human breast cancer cells. Proc. Natl Acad. Sci. USA 92(21), 9747-9751 (1995
74. Bahrami S, Duch M, Pederson FS. Ligand presentation on a synthetic flexible hinge in Moloney murine leukemia virus SU supports entry through a heterologous receptor. Virology 363, 303-309 (2007
75. Hall FL, Gordon EM, Wu L et al. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 Envelope protein. Hum. Gene. Ther. 8, 2183-2192 (1997
76. Hall F, Liu L, Zhu N et al. Molecular engineering of matrix-Targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand Factor. Hum. Gene. Ther. 11(983-993), (2000
77. Gordon E, Chen Z, Ling L et al. Systemic administration of a matrix-Targeted retroviral vector Is efficacious for cancer gene therapy in mice. Hum. Gene. Ther. 12(2), 193-204 (2001
78. Gordon E, Liu P, Chen Z et al. Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-Targeted retroviral vectors bearing a cytocidal cyclin G1 construct. Cancer Res. 60, 3343-3347 (2000
79. Chawla S, Chua V, Fernandez L et al. Advanced Phase I/II studies of targeted gene delivery in vivo: Intravenous rexin-G for gemcitabine-resistant metastatic pancreatic cancer. Mol. Ther. 18(2), 435-451 (2010
80. Chawla S, Chua V, Fernandez L et al. Phase I/II and Phase II studies of targeted gene delivery in vivo: Intravenous rexin-G for chemotherapy-resistant sarcoma and osteosarcoma. Mol. Ther. 17(9), 1651-1657 (2009
81. Galanis E, Carlson S, Foster N et al. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol. Ther. 16(5), 979-984 (2008
82. Ziegler L, Yang L, Joo K, Yang H, Baltimore D, Wang P. Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum. Gene. Ther. 19(9), 861-872 (2008
83. Lin A, Kasahara N, Wu W et al. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein. Hum. Gene. Ther. 12(4), 323-332 (2001
84. Li F, Ryu B, Krueger R, Heldt S, Albritton L. Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-Type viral glycoproteins. J. Virol. 86(1), 373-381 (2012
85. Bahrami S, Pagh K, Ejegod D, Duch M, Tolstrup M, Pedersen FS. Construction of a gammaretrovirus with a novel tropism and wild-Type replication kinetics capable of using human APJ as entry receptor. J. Virol. 86(19), 10621-10627 (2012
86. Katane M, Takao E, Kubo Y, Fujita R, Amanuma H. Factors affecting the direct targeting of murine leukemia virus vectors containing peptide ligands in the envelope protein. EMBO Rep. 3(9), 899-904 (2002
87. Peng KW, Morling FJ, Cosset FL, Murphy G, Russell SJ. A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum. Gene. Ther. 8, 729-738 (1997
88. Morling F, Peng K, Cosset F, Russell S. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. Virology 234(1), 51-61 (1997
89. Solly S, Nguyen T, Weber A, Horellou P. Targeting of c-Met and urokinase expressing human glioma cell lines by retrovirus vector displaying single-chain variable fragment antibody. Cancer Biol. Ther. 4(9), 987-992 (2005
90. Peng K, Morling F, Cosset F-L, Russell S. A retroviral gene delivery system activatable by plasmin. Tumor Targeting 3, 112-120 (1998
91. Buchholz CJ, Peng K-W, Morling FJ, Zhang J, Cosset F-L, Russell SJ. In vivo selection of protease cleavage sites from retrovirus display libraries. Nat. Biotechnol. 16, 951-954 (1998
92. Bahrami S, Duch M, Pedersen FS. Change of tropism of SL3-2 murine leukemia virus, using random mutational libraries. J. Virol. 78(17), 9343-9351 (2004
93. Soong N, Nomura L, Pekrun K et al. Molecular breeding of viruses. Nat. Genet. 25(4), 436-439 (2000
94. Eiden MV, Farrell K, Wilson CA. Glycosylation-dependent inactivation of the ecotropic murine leukemia virus receptor. J. Virol. 68(2), 626-631 (1994
95. Argaw T, Figueroa M, Salomon DR, Wilson CA. Identification of residues outside of the receptor binding domain that influence infectivity and tropism of porcine endogenous retrovirus. J. Virol. 82(15), 7483-7491 (2008
96. Gemeniano M, Mpanju O, Salomon DR, Eiden MV, Wilson CA. The infectivity and host range of the ecotropic porcine endogenous retrovirus, PERV-C, is modulated by residues in the C-Terminal region of its surface envelope protein. Virology 446(1), 108-117 (2006
97. Bolin L, Chandhasin C, Lobelle-Rich P, Albritton L, Levy L. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum. Retrovirology 8, 35 (2011
98. Bupp K, Roth MJ. Targeting a retroviral vector in the absence of a known cell-Targeting ligand. Hum. Gene. Ther. 14, 1557-1564 (2003
99. Bupp K, Sarangi A, Roth MJ. Probing sequence variation in the receptor-Targeting domain of feline leukemia virus envelope proteins with peptide display libraries. J. Virol. 79(3), 1463-1469 (2005
100. Bupp K, Sarangi A, Roth MJ. Selection of feline leukemia virus envelope proteins from a library by functional association with a murine leukemia virus envelope. Virology 351, 340-348 (2006
101. Kamiyama S, Sasaki N, Goda E et al. Molecular cloning and characterization of a novel 3́-phosphoadenosine 5́-phosphosulfate transporter, PAPST2. J. Biol. Chem. 281(16), 10945-10953 (2006
102. Ishida N, Kuba T, Aoki K, Miyatake S, Kawakita M, Sanai Y. Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family. Genomics 85(1), 106-116 (2005
103. Mazari P, Argaw T, Valdivieso L et al. Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A. Virology 427(2), 118-126 (2012
104. Takeuchi Y, Patience C, Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72(12), 9986-9991 (1998
105. Lu Y, Yi Y, Liu P et al. Common human cancer genes discovered by integrated gene-expression analysis. Plos One 2(11), e1149 (2007
106. Bu L, Jiang G, Yang F, Liu J, Wang J. Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging. Mol. Med. Rep. 4(6), 1289-1293 (2011
107. Morizono K, Xie Y, Helguera G et al. A versatile targeting system with lentiviral vectors bearing the biotin adaptor peptide. J. Gene Med. 11(8), 655-663 (2009
108. Zhang X, Roth M. Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells. J. Gene Med. 12(12), 945-955 (2010
109. Wu D, Selta Y, Zhang X, Lu C, Roth M. Antibody-directed lentiviral transduction for live-cell monitoring and selection of human iPS and hES cells. Plos One 7(4), e34778 (2012
110. Bates P, Young JAT, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74, 1043-1051 (1993
111. Adkins HB, Brojatsch J, Naughton J, Rolls J, Pesola MM, Young JA. Identification of a cellular receptor for subgroup E avian leukosis virus. Proc. Natl Acad. Sci. USA 94(21), 11617-11622. (1997
112. Adkins HB, Brojatch J, Young JA. Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry. J. Virol. 74(8), 3572-3578 (2000
113. Elleder D, Stepanets V, Melder DC et al. The receptor for the subgroup C avian sarcoma and leukosis viruses, Tvc, is related to mammalian butyrophilins, members of the immunoglobulin superfamily. J. Virol. 79(16), 10408-10419 (2005
114. Albritton LM, Tweng L, Scadden D, Cunningham JM. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57, 659-666 (1989
115. Kozak CA, Albritton LM, Cunningham J. Genetic mapping of a cloned sequence responsible for susceptibility to ecotropic murine leukemia virus. J. Virol. 64(6), 3119-3121 (1990
116. Kim JW, Closs EI, Albritton LM, Cunningham JM. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725-728 (1991
117. Miller DG, Miller AD. A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68, 8270-8276 (1994
118. Johann SV, Gibbons JJ, O'Hara B. GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J. Virol. 66, 1635-1640 (1992
119. Kavanaugh MP, Miller DG, Zhang W et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl Acad. Sci. USA 91(15), 7071-7075 (1994
120. Vanzeijl M, Johann SV, Closs E et al. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl Acad. Sci. USA 91(3), 1168-1172 (1994
121. Miller DG, Edwards RH, Miller AD. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl Acad. Sci. USA 91, 78-82 (1994
122. Vaughan AE, Mendoza R, Aranda R, Battini JL, Miller AD. Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity. J. Virol. 86(3), 1661-1669 (2012
123. Yang Y, Guo L, Xu S et al. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat. Genet. 21(2), 216-219 (1999
124. Tailor CS, Nouri A, Lee CG, Kozak C, Kabat D. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl Acad. Sci. USA 96, 927-932 (1999
125. Battini J, Rasko J, Ad. M. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction. Proc. Natl Acad. Sci. USA 96(4), 1385-1390. (1999
126. O'Hara B, Johann SV, Klinger HP et al. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Different. 1, 119-127 (1990
127. Kaelbling M, Eddy R, Shows TB et al. Localization of the human gene allowing infection by the gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2. J. Virol. 65(4), 1743-1747 (1991
128. Ericsson TA, Takeuchi Y, Templin C et al. Identification of receptors for pig endogenous retrovirus.Proc. Natl Acad. Sci. USA 100(11), 6759-6764(2003
129. Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am. J. Physiol. Cell Physiol. 295(3), C632-C641 (2008
130. Yao Y YA, Yoshimatsu H, Masuda S, Katsura T, Inui K. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J. Nutr. 140(7), 1220-1226 (2010
131. Mendoza R, Anderson MM, Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J. Virol. 80(7), 3378-3385 (2006
132. Takeuchi Y, Vile RG, Simpson G, O'Hara B, Collins MKL, Weiss RA. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 66, 1219-1222 (1992
133. Quigley JG, Burns CC, Anderson MM et al. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95(3), 1093-1099 (2000
134. Quigley JG, Yang Z, Worthington MT et al. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118(6), 757-766 (2004
135. Tailor CS, Nouri A, Zhao Y, Takeuchi Y, Kabat D. A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73, 4470-4474 (1999